Abstract | PURPOSE: METHODS: RESULTS: One month after the second intravitreal injection of propranolol, fluorescein leakage decreased from the tumors located on the optic nerve head and in the inferonasal retinal periphery. Reduction of the retinal capillary hemangioma vascularity and enhancement of its fibrosis associated with the attenuation of the feeder vessel were also observed. Ophthalmic examination showed no adverse effect except for a mild transient vitreous haziness after each injection. Electroretinogram performed 4 weeks after the first injection revealed no retinal toxicity. CONCLUSION:
|
Authors | Saeed Karimi, Homayoun Nikkhah, Hamid Ahmadieh, Sare Safi |
Journal | Retinal cases & brief reports
(Retin Cases Brief Rep)
Vol. 14
Issue 4
Pg. 305-309
( 2020)
ISSN: 1937-1578 [Electronic] United States |
PMID | 29466252
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Adrenergic beta-Antagonists
- Propranolol
|
Topics |
- Adrenergic beta-Antagonists
(therapeutic use)
- Adult
- Electroretinography
- Fluorescein Angiography
- Hemangioma, Capillary
(diagnosis, drug therapy, etiology)
- Humans
- Intravitreal Injections
- Male
- Propranolol
(therapeutic use)
- Retinal Neoplasms
(diagnosis, drug therapy, etiology)
- Tomography, Optical Coherence
- Visual Acuity
(physiology)
- von Hippel-Lindau Disease
(complications)
|